Table 6.
Clinical analysis of hepatic failure treated by nonbioartificial liver treatment.
| Index | Mean (before and after) | Standard deviation (front and back) | The value of P |
|---|---|---|---|
| ALT(U/L) | 117.06, 69.60 | 236.50, 76.28 | 0.051 |
| AST(U/L) | 185.15, 141.23 | 250.61, 138.12 | 0.003∗ |
| ALB(g/L) | 30.59, 28.33 | 4.61, 2.81 | 0.001∗∗ |
| ALP(U/L) | 95.54, 86.33 | 33.33, 31.24 | 0.01∗ |
| r-GT(U/L) | 60.77, 49.06 | 36.66, 21.87 | 0.003∗ |
| TBil(umol/L) | 372.53, 263.53 | 229.01, 170.05 | 0.001∗∗ |
| PT(s) | 24.66, 19.74 | 8.36, 5.82 | 0.001∗∗ |
Note.∗Compared with the preclinical indexes in the nonbioartificial liver treatment P < 0.01. ∗∗Compared with the preclinical indexes in the nonbioartificial liver treatment P ⩽ 0.001. There was significant statistical significance.